PHGE

BiomX Inc. (PHGE) is a cutting-edge clinical-stage microbiome therapeutics company headquartered in Ness Ziona, Israel. The firm leverages both natural and engineered phage technologies to combat pathogenic bacterial infections and address chronic diseases linked to dysbiosis, with a robust pipeline targeting conditions such as inflammatory bowel disease, cystic fibrosis, and acne. BiomX's dedication to advancing microbial therapeutics positions it to fulfill critical unmet medical needs and spearhead innovation within the healthcare sector.